Clinician hub
Advancing Objective Immune Data for PAIS.
PAIS affect millions of people globally, yet clinicians still lack widely adopted objective tools to assess underlying immune dysfunction. ViraxImmune™ is being developed to characterise antigen-specific T cell responses and patterns of cellular immune dysregulation, with the aim of reducing diagnostic uncertainty and supporting patient stratification.
Explore Scientific Resources
Patient stratification & clinical utility
Overcoming Diagnostic Uncertainty in Daily Practice.
Clinical assessment of suspected PAIS can be challenging because symptoms overlap with other conditions and there are no widely adopted objective tools for assessing associated immune dysfunction.
ViraxImmune™ is being developed to provide an objective cellular immune profile that complements symptom history and other clinical findings, with an initial focus on PAIS. Our platform may help reduce diagnostic uncertainty and support patient stratification.
As clinical evidence and treatment pathways evolve, objective tools for characterising relevant immune-response patterns may become increasingly important.
01
Objective Immune Data
ViraxImmune™ is being developed to provide an objective immune-dysfunction profile to complement symptom history and other clinical findings.
02
Patient Stratification
As treatment pathways for PAIS evolve, objective tools to identify and stratify relevant patient populations will become increasingly important.
03
Potential Clinical Relevance
ViraxImmune™ is being developed to characterise cellular immune-response patterns that may complement clinical assessment and support patient stratification.
ViraxImmune™ is not intended to replace clinical judgment or independently determine treatment. Intended use and performance remain subject to validation and regulatory review.
Scientific Resources & Emerging Evidence
The Evidence Base.
Explore clinical study information, conference materials, scientific overviews and peer-reviewed publications relating to the development of ViraxImmune™ and T cell profiling in PAIS.
- Publications & Conference Materials
Poster presented at WIRM 2025
Evaluation of T cell dysfunction in post-acute infection syndromes (PAIS)
Download Document
- Publications & Conference Materials
Poster presented at BSI 2025
T cell dysfunction in post-acute infection syndromes (PAIS)
Download Document
- Whitepapers & Overviews
ViraxImmune™ Platform Overview
A concise introduction to the platform, its initial focus on PAIS, and its broader potential in immune profiling and immune monitoring.
Download Document
- Whitepapers & Overviews
T Cell Profiling in Post-Acute Infection Syndromes
An overview of cellular immune profiling, and why T cell responses are being investigated in chronic post-infectious conditions.
Download Document
Additional clinical publications, conference materials, and study results, will be added as the ViraxImmune™ evidence base develops. Check back regularly for new content.